4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000069
Chief Medical Officer returned 3,047 shares (to the company)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nuyten Dimitry SA · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-18 | Returned to the company : show line 1 in the form 10b5-1 | −1,507 | $17.74 | $26,734 | 72,735 | D |
| 2023-12-19 | Returned to the company : show line 2 in the form 10b5-1 | −1,540 | $18.09 | $27,859 | 71,195 | D |
Loading xslF345X05/wk-form4_1703106628.xml…